Lupin Limited (BOM:500257)
India · Delayed Price · Currency is INR 2,165.05
+25.65 (1.20%)
At close: Jan 22, 2026
Lupin Market Cap
Lupin has a market cap or net worth of 976.25 billion as of January 23, 2026. Its market cap has decreased by -9.63% in one year.
Market Cap
976.25B
Enterprise Value
976.55B
Revenue
247.51B
Ranking
n/a
PE Ratio
22.63
Stock Price
2,165.05
Market Cap Chart
Since September 29, 1999, Lupin's market cap has increased from 998.14M to 976.25B, an increase of 97,706.85%. That is a compound annual growth rate of 29.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 988.99B | 2.51% |
| Dec 31, 2025 | 964.76B | -10.05% |
| Dec 31, 2024 | 1.07T | 78.05% |
| Dec 29, 2023 | 602.42B | 80.75% |
| Dec 30, 2022 | 333.29B | -22.86% |
| Dec 31, 2021 | 432.05B | -2.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.35T |
| Dr. Reddy's Laboratories | 971.48B |
| Abbott India | 578.31B |
| GlaxoSmithKline Pharmaceuticals | 384.52B |
| J. B. Chemicals & Pharmaceuticals | 294.79B |
| AstraZeneca Pharma India | 206.24B |
| Jubilant Pharmova | 150.52B |
| Caplin Point Laboratories | 135.05B |